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CDKL5 disorder is a severe neurodevelopmental disorder caused bymutations in the X-linkedCDKL5 (cyclin-dependent kinase-like
five) gene. CDKL5 disorder primarily affects girls and is characterized by early-onset epileptic seizures, gross motor impairment,
intellectual disability, and autistic features. Although all CDKL5 female patients are heterozygous, the most valid disease-related
model, the heterozygous female Cdkl5 knockout (Cdkl5 +/−) mouse, has been little characterized. The lack of detailed behavioral
profiling of this model remains a crucial gap that must be addressed in order to advance preclinical studies. Here, we provide a
behavioral and molecular characterization of heterozygous Cdkl5 +/− mice. We found that Cdkl5 +/− mice reliably recapitulate
several aspects of CDKL5 disorder, including autistic-like behaviors, defects in motor coordination and memory performance,
and breathing abnormalities. These defects are associated with neuroanatomical alterations, such as reduced dendritic
arborization and spine density of hippocampal neurons. Interestingly, Cdkl5 +/− mice show age-related alterations in protein
kinase B (AKT) and extracellular signal-regulated kinase (ERK) signaling, two crucial signaling pathways involved in many
neurodevelopmental processes. In conclusion, our study provides a comprehensive overview of neurobehavioral phenotypes of
heterozygous female Cdkl5 +/− mice and demonstrates that the heterozygous female might be a valuable animal model in
preclinical studies on CDKL5 disorder.
1. Introduction
Cyclin-dependent kinase-like 5 (CDKL5) disorder (OMIM
no. 300203) is a severe neurodevelopmental disorder caused
by mutations in the X-linked CDKL5 gene. Primary clinical
features include early-onset intractable epileptic seizures,
gross motor impairment, severe intellectual disability, and
autistic-like features [1–4]. The majority of CDKL5 patients
are heterozygous females carrying missense, nonsense, splice,
or frameshift CDKL5 gene mutations or a genomic deletion
[5]. Due to the different CDKL5 mutations and the variable
X-chromosome random inactivation (XCI) in females, the
phenotypic spectrum of the disease spans from milder for-
ms—which include the possibility of autonomous walking
and less severe epilepsy that is amenable to control—to
severe forms featuring intractable seizures, more severe
microcephaly and the absence of motor milestones. Boys car-
rying mutations in CDKL5 are much rarer and show more
severe epileptic encephalopathy than girls [6, 7], probably
due to the more severe consequences of dominant X-linked
mutations in males than in females.
CDKL5 encodes a ubiquitously expressed serine/
threonine kinase whose catalytic domains share homology
with members of the cyclin-dependent kinase family and
mitogen-activated protein kinases [8]. CDKL5 is expressed
at high levels in the brain, reaching a peak during postnatal
development, when crucial events, such as neuronal matura-
tion and synaptogenesis, occur [9, 10]. CDKL5 is mainly
expressed in neurons and is distributed in the cell nucleus
and cytoplasm, as it shuttles between these cellular
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compartments [9]. The identification of the molecular targets
of CDKL5 has started to shed light on the role of CDKL5 in
neurodevelopment. The CDKL5 substrates that have, so far,
been identified are MeCP2 [11, 12], DNA methyltransferase
1 (DNMT1) [13], Rac1 [14], amphiphysin 1 [15], PSD-95
[16], NGL-1 [17], Mind Bomb 1 (Mib1) [18], Shootin1 [19],
HDAC4 [20], and IQGAP1 [21]. Furthermore, different sig-
naling networks are affected by the absence of CDKL5 [22].
Interestingly, loss of CDKL5 alters Akt-mTOR and Akt-
GSK3-β signaling pathways [22–25]. Notably, mutations
and dysfunction of components of these pathways have been
implicated in the etiology of several neurodevelopmental dis-
orders, such as autism, Rett syndrome, Fragile X syndrome,
and tuberous sclerosis [26–28].
Several Cdkl5 knockout (KO) mouse models have been
generated to understand how CDKL5 dysfunction leads to
neurological defects in CDKL5 disorder [22, 23, 29, 30].
Despite the lack of overt epilepsy, Cdkl5 KO mice exhibit
numerous behavioral deficits across motor, sensory, cogni-
tive, and socioemotional domains that are reminiscent of
human symptomatology [22–25, 29, 31, 32]. These behav-
ioral defects are associated with morphological alterations,
such as reduced dendritic arborization of hippocampal and
cortical neurons, deficits in dendritic spine density and
organization, and altered connectivity [20, 23–25, 33–35].
However, the majority of work involving Cdkl5 KO mouse
models has focused on the loss of Cdkl5 in male mice and
only a few studies have included an initial characterization
of heterozygous female Cdkl5 KO mice [23, 25, 36]. An
extensive behavioral characterization of heterozygous Cdkl5
KO females is still missing, and this represents a critical
gap, since heterozygous Cdkl5 KO female mice better recapit-
ulate the mosaic distribution of mutant cells present in the
majority of CDKL5 patients. Given the clinical relevance of
CDKL5 disorder in females, the aim of our current study
was to evaluate the behavioral abnormalities in heterozygous
Cdkl5 KO female mice (Cdkl5 +/−) compared to homozy-
gous Cdkl5 KO (Cdkl5 −/−) and wild-type (Cdkl5 +/+)
female mice, focusing on cognitive (learning and memory)
behaviors, motor activity and coordination, social behaviors,
and breathing pattern, features that are particularly compro-
mised in CDKL5 patients. Since behavioral abnormalities are
the main biomarkers of CDKL5 disorder, our study may cru-
cially define the validity of the heterozygous Cdkl5 KO
murine models for this disorder.
2. Experimental Procedures
2.1. Animal Husbandry. The mice used in this work derive
from the Cdkl5 null strain in the C57BL/6N background
developed in [23] and backcrossed in C57BL/6J for three
generations. Heterozygous Cdkl5 KO (+/−) and homozygous
Cdkl5 KO (−/−) females were produced and karyotyped as
previously described [23]. Age-matched controls (wild-type
females (+/+), when possible littermates) were used for all
experiments. Mice were housed three to five animals per cage
and maintained on a 12 h light: 12 h dark cycle in a tempera-
ture- (23°C) and humidity-controlled environment with
standard mouse chow and water ad libitum. The animals’
health and comfort were controlled by the veterinary service.
All research and animal care procedures were performed in
accordance with the Italian and European Community law
for the use of experimental animals and were approved by
Bologna University Bioethical Committee. In this study, all
efforts were made to minimize animal suffering and to keep
the number of animals used to a minimum.
2.2. Western Blotting. Western blot analysis was conducted
on independent cohorts of 3-week-, 8-week-, and 12–14-
week-old mice (n = 3 – 8 for each genotype) that had not
undergone behavioral assessment. Animals were euthanized
with isoflurane (2% in pure oxygen) and sacrificed by cervical
dislocation. The brain was quickly removed, and the somato-
sensory cortex, the hippocampal formation, and the cerebel-
lum were homogenized in ice-cold RIPA buffer (50mM
Tris-HCl, pH7.4, 150mM NaCl, 1% Triton-X100, 0.5%
sodium deoxycholate, and 0.1% SDS) supplemented with
1mM PMSF and 1% protease and phosphatase inhibitor
cocktail (Sigma-Aldrich). Extracts were immediately proc-
essed by Western blot or kept frozen (−80°C) until assayed.
Protein concentration was determined by the Lowry method
[37]. Equivalent amounts (10μg) of protein were subjected
to electrophoresis on a BOLT Bis-Tris Plus gel (Thermo
Fisher Scientific) and transferred to a Hybond ECL nitrocel-
lulose membrane (Amersham Life Science). The following
primary antibodies were used: sheep polyclonal anti-
CDKL5 (1 : 1000, MRC Protein Phosphorylation and
Ubiquitylation Unit—University of Dundee, UK), rabbit
polyclonal anti-GAPDH (1 : 5000, Sigma-Aldrich), mouse
monoclonal β-catenin (1 : 1000, BD Transduction Laborato-
ries), rabbit polyclonal anti-phospho-AKT (Ser473)
(1 : 1000), rabbit polyclonal anti-AKT (1 : 1000), rabbit poly-
clonal anti-phospho-ERK1/2 (1 : 1000), mouse monoclonal
anti-ERK1/2 (1 : 1000), and rabbit polyclonal anti-phospho-
MSK1 (Thr 581) (1 : 1000, Cell Signaling Technology). The
following secondary antibodies were used: HRP-conjugated
goat anti-sheep IgG, HRP-conjugated goat anti-mouse IgG,
and HRP-conjugated goat anti-rabbit IgG (1 : 5000, Jackson
ImmunoResearch) antibodies. Densitometric analysis of dig-
itized images was performed using Chemidoc XRS Imaging
Systems and Image Lab™ Software (Bio-Rad).
2.3. Histological and Immunohistochemistry Procedures.
Histological analysis was conducted on independent cohorts
of 14-week-old mice (n = 3 − 4 for each genotype) that had
not undergone behavioral assessment. Animals were eutha-
nized with isoflurane (2% in pure oxygen) and sacrificed by
cervical dislocation. Brains were quickly removed and cut
along the midline. Right hemispheres were processed for
immunohistochemistry procedure, while left hemispheres
were Golgi-stained as described below. All steps of section-
ing, imaging, and data analysis were conducted blindly.
PSD-95 immunohistochemistry—right hemispheres were
fixed by immersion in 4% paraformaldehyde in 100mM
phosphate buffer, pH7.4, stored in fixative for 48 h, kept in
20% sucrose for an additional 24 h, and then frozen with cold
ice. Right hemispheres were cut with a freezing microtome
into 30μm thick coronal sections that were serially collected.
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One out of 12 free-floating sections from the hippocampal
formation were incubated for 24h at 4°C with a rabbit poly-
clonal anti-PSD-95 antibody (1 : 1000; Abcam). Sections were
then incubated at room temperature for 2 h with a CY3-
conjugated goat anti-rabbit IgG (1 : 200; Jackson ImmunoRe-
search). For quantification of PSD-95 immunoreactive
puncta, images from the molecular layer of the hippocampal
dentate gyrus were acquired using a Leica TCS SL confocal
microscope (Leica Mycrosytems; 63x oil immersion objec-
tive, NA 1.32; zoom factor = 8). Three to four sections per
animal were analyzed. Counting was carried out using Image
Pro Plus software (Media Cybernetics), and the number of
PSD-95 immunoreactive puncta was expressed per μm2.
Golgi staining—left hemispheres were Golgi-stained using
the FD Rapid GolgiStain TM Kit (FD NeuroTechnologies).
Briefly, hemispheres were immersed in the impregnation
solution containing mercuric chloride, potassium dichro-
mate, and potassium chromate and stored at room tempera-
ture in darkness for 2–3 weeks. Hemispheres were cut with a
microtome in 100μm thick coronal sections that were
directly mounted on gelatin-coated slides and were air-
dried at room temperature in the dark for an additional 2–3
days. After drying, sections were rinsed with distilled water
and subsequently stained in the developing solution of the
kit. A light microscope (Leica Mycrosystems) equipped with
a motorized stage and focus control system and a color digital
camera (CoolSNAP-Pro; Media Cybernetics) were used for
neuronal tracing and to take bright-field images. Measure-
ments were carried out using Image Pro Plus software (Media
Cybernetics). Neuronal tracing—a series of sections across
the whole rostrocaudal extent of the hippocampal dentate
gyrus were used for reconstruction of Golgi-stained neurons.
Golgi-stained neurons (15–20 per animal) were sampled
from the outer part of the granule cell layer and traced with
a dedicated software custom-designed for dendritic recon-
struction (Immagini Computer, Milan, Italy), interfaced with
Image Pro Plus (Media Cybernetics). The dendritic tree was
traced live, at a final magnification of 500x, by focusing into
the depth of the section. The operator starts with branches
emerging from the cell soma and after having drawn the first
parent branch goes on with all daughter branches of the next
order in a centrifugal direction. At the end of tracing, the pro-
gram reconstructs the total dendritic length, the mean length
of branches, and the number of branches. Spine density and
morphology—in Golgi-stained sections, spines of granule
neurons were counted using a 100x oil immersion objective
lens. Dendritic spine density was measured by manually
counting the number of dendritic spines on dendritic
segments in the molecular layer and expressed as the
number of dendritic spines per μm. Based on their mor-
phology, dendritic spines can be divided into five different
classes (immature spines: filopodium-like, thin-shaped,
and stubby-shaped; mature spines: mushroom- and cup-
shaped), which also reflect their state of maturation. The
total number of spines was expressed per μm, and the
number of spines belonging to each class was counted
and expressed as a percentage. About 200–250 spines from
25 to 30 dendrites derived from 12 to 15 neurons were
analyzed per condition.
2.4. Behavioral Assays. All animal behavioral studies and
analysis were performed blinded to genotype. Mice were
allowed to habituate to the testing room for at least 1 h before
the test, and testing was performed at the same time of day.
All animal behaviors were tested at 12–16 weeks of age.
2.5. Test Cohorts.A total of 124 animals separated in six inde-
pendent test cohorts were used for neurobehavioral studies.
The sequence of the tests was arranged to minimize the effect
of one test influencing subsequent evaluation of the next test,
and mice were allowed to recover several days between
different tests. The first test cohort consisted of 26 animals
(+/+ n = 7, +/− n = 9, and −/− n = 10) that were tested with
the following assays at indicated time points: buried food
test, 12 weeks; accelerating rotarod assay, 13 weeks; open
field, 14 weeks; and Morris water maze, 14–15 weeks.
The second cohort consisted of 11 animals (+/+ n = 4, +/−
n = 2, and −/− n = 5) that were tested with the following
assays at indicated time points: buried food test, 12 weeks;
open field, 14 weeks; and Morris water maze, 14–15 weeks.
The third cohort consisted of 19 animals (+/+ n = 5, +/−
n = 8, and −/− n = 7) that were tested with the following
assays at the indicated time points: nesting, 12 weeks; acceler-
ating rotarod assay, 12 weeks; marble burying, 13 weeks;
open field, 14 weeks; Morris water maze, 14–15 weeks; and
passive avoidance, 16 weeks. The fourth test cohort consisted
of 19 animals (+/+ n = 8, +/− n = 4, and −/− n = 7) that were
tested with the following assays at the indicated time points:
accelerating rotarod assay, 12 weeks; marble burying, 13
weeks; Morris water maze, 14–15 weeks; and passive avoid-
ance, 16 weeks. The fifth test cohort consisted of 23 animals
(+/+ n = 5, +/− n = 8, and −/− n = 10) that were tested for
nesting at 12 weeks of age or with the buried food test
or the marble burying test at 13 weeks of age. The sixth test
of cohort consisted of 26 animals (+/+ n = 9, +/− n = 11,
and −/− n = 8) that were tested for breathing abnormalities
at 14 weeks and body weight at 8 and 14 weeks.
2.6. Buried Food Test. The buried food test relies on the ani-
mal’s ability to smell volatile odors and its natural tendency
to use olfactory cues for foraging. The testing protocol of 3
days consists of an odor familiarization exercise on day 1,
food deprivation on day 2, and testing on day 3. On day 1,
mice were placed in a clean cage and a piece of cookie
(exactly the same kind as in the test) was placed in each cage
and left overnight. Cages were inspected on day 2 to verify
that the cookies had been consumed, thus verifying that
the bait was highly palatable. On day 2, mice were
deprived of food for 24 h, and the test was performed on
day 3. Mice were individually introduced into a clean cage
containing 4 cm of deep clean bedding and allowed to
acclimate to the cage for 5min to reduce the interference
of novel environment exploration during the test. A cookie
was buried beneath 1 cm of bedding in a random corner
of the cage, and the mouse was introduced into the cage.
The time necessary for the animal to retrieve the cookie
with its front paws was measured in seconds (latency)
up to a maximum of 15min (900 s).
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2.7. Nesting. Nest building ability was evaluated as proposed
by Deacon [38]. Animals were placed in individual cages with
standard bedding, and a standard piece of paper towel
(23 cm× 23 cm) was provided. The nests were independently
assessed at 3 and 22 h by two operators using the following
scoring system: 0—no nest, 1—primitive flat nest (pad-
shaped, consisting of a flat paper tissue which slightly elevates
a mouse above the bedding), 2—more complex nest (includ-
ing warping and biting the paper towel), 3—complex accu-
rate cup-shaped nests (with shredded paper interwoven to
form the walls of the cup), and 4—complex hooded nest, with
walls forming a ceiling so the nest becomes a hollow sphere
with one opening.
2.8. Marble Burying. The marble burying test was performed
by placing animals individually in a home-cage-like environ-
ment with 5 cm of unscented standard bedding material and
20 marbles (14.3mm in diameter) arranged in a 4× 5 matrix
and left undisturbed for 30min. The number of marbles
that were at least two-thirds buried at the end of the trial
was counted.
2.9. Accelerating Rotarod Assay. Before the first test session,
animals were briefly trained at a constant speed of 5 rpm on
the rotarod apparatus (Ugo Basile) for 30 s. Thirty minutes
later, testing was performed at an accelerating linear speed
(5–35 rpm within 270 s + 30 s max speed). Four testing trials
with an intertrial interval of 1 h were performed. The latency
to fall from the rotating rod and the number of passive rota-
tions (rotation in which the mouse does not perform any
coordinated movement but is passively transported by the
rotating apparatus) were recorded for each trial.
2.10. Open Field. In order to assess locomotion, animals were
placed in the center of a square arena (50× 50 cm) and their
behavior was monitored for 20min using a video camera
placed above the center of the arena. Distinct features of
locomotor activity, including total distance traveled, average
locomotion velocity, and the time spent at the border, by
the walls, and in the center, were scored by EthoVision10XT
software (Noldus Information Technology B.V., The Nether-
lands). The numbers of stereotypical jumps (repetitive beam
breaks < 1 s) in the corners of the arena were manually
counted by a trained observer who was blind to the genotype.
The test chambers were cleaned with 70% ethanol between
test subjects. To evaluate whether Cdkl5 KO female mice
show stereotypic behaviors also in the home-cage environ-
ment, animals were single-caged for 48 h and stereotypic
jumps were evaluated in a time window of 20min.
2.11. Morris Water Maze. Hippocampal-dependent spatial
learning and memory was assessed using the Morris water
maze (MWM). Mice were trained to locate a hidden escape
platform in a circular pool. The apparatus consisted of a
circular water tank (1m in diameter, 50 cm high) with a
transparent round escape platform (10 cm2) placed in a fixed
position. The tank was filled with tap water at a temperature
of 22°C up to 0.5 cm above the top of the platform, and the
water was made opaque with milk. In the experimental room,
intramaze and extramaze visual cues were placed to enable
spatial orientation. Mouse behavior was automatically video-
tracked (EthoVision 3.1; Noldus Information Technology
B.V.). During training, each mouse was subjected to either
1 swimming session of 4 trials (day 1) or 2 sessions of 4 trials
per day (days 2–5), with an intersession interval of 1 h (acqui-
sition phase). Mice were allowed to search for the platform
for up to 60 s. If a mouse did not find the platform, it was
gently guided to it and allowed to remain there for 15 s. Dur-
ing the intertrial-interval (15 s), mice were placed in an
empty cage. The latency to find the hidden platform was used
as a measure of learning. Twenty-four h after the last acqui-
sition trial, on day 6, the platform was removed and a probe
test was run. Animals were allowed to search for the platform
for up to 60 s. The latency of the first entrance into the former
platform area, the frequency of entrances and the time spent
in the quadrant in which the platform had been located dur-
ing training, and the proximity to the former platform quad-
rant (Gallagher’s test) were employed as measures of
retention of acquired spatial preference. During the learning
phase, the average and maximum swim speeds were also ana-
lyzed. The percentage of floating was defined as the percent-
age of time swimming at a speed slower than 4 cm/s. Animals
that failed the visual clue test were excluded from the analysis
(+/− n = 1 and −/− n = 3).
2.12. Passive Avoidance. For the passive avoidance task, a
memory task that involves contributions from both the hip-
pocampus and amygdala, we used a tilting-floor box
(47× 18× 26 cm) divided into 2 compartments (lit and dark)
by a sliding door and a control unit incorporating a shocker
(Ugo Basile). This classic instrument for Pavlovian condi-
tioning exploits the tendency in mice to escape from an
illuminated area into a dark one (step-through method). In
general, mice step quickly through the gate and enter the
dark compartment (innate preference for the dark compart-
ment). Upon entering the dark compartment, mice received
a brief mild foot shock (0.4mA for 3 s) and were removed
from the chamber after a 15 s delay. The chambers were
cleaned with 70% ethanol between testing one subject and
another. After a 24h retention period, mice were placed back
into the illuminated compartment and the latency to reenter
the dark chamber was measured up to 358 s.
2.13. Noninvasive Assessment of Sleep and Breathing Pattern.
Hypnic and respiratory phenotypes of mice were assessed
noninvasively with a validated technique based on whole-
body plethysmography (WBP) [39, 40]. Briefly, each mouse
was placed inside a WBP chamber flushed with air at 1.5 l/h
for the first 8 h of the light period. The respiratory (WBP
chamber pressure) signal was continuously recorded together
with chamber humidity and temperature, digitized, and
stored at 128Hz, 4Hz, and 4Hz, respectively. The system
was calibrated with a 100μl micro-syringe (Hamilton, Reno,
USA) at the end of each recording. The states of wakefulness,
nonrapid eye movement sleep (NREMS), and rapid eye
movement sleep (REMS) were scored based on inspection
of the raw WBP signal with the investigators blinded to the
animal’s genotype. Quantitative analysis of breathing was
restricted to stable sleep episodes ≥ 12 s because of the
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frequent occurrence of movement artefacts during wakeful-
ness. Apneas were automatically detected as breaths with
instantaneous total breath duration TTOT > 3 times; the
average TTOT for each mouse and sleep state and detection
accuracy were checked on raw recordings.
2.14. Statistical Analysis. Data from single animals repre-
sented the unity of analysis. Results are presented asmean ±
standard error of themean (± SE). Statistical analysis was per-
formedwith SPSS (version23) orGraphPadPrism (version 6).
All datasets were analyzed using the ROUTmethod (Q = 1%)
to identify significant outliers and the Shapiro-Wilk test for
normality. Datasets with normal distribution were analyzed
for significance using a one-way analysis of variance
(ANOVA) with genotype as a factor. Post hoc multiple com-
parisons were carried out using the Fisher least significant dif-
ference (Fisher’s LSD) test. Datasets with nonparametric
distributionwere analyzedusing theKruskal-Wallis test. Post
hoc multiple comparisons were carried out using Dunn’s
multiple comparison test or the Mann–Whitney test. For
the rotarod assay and the learning phase of the MWM
test, statistical analysis was performed using a repeated
ANOVA. For categorical data, that is, percentages of
spines, we used a chi-squared test. A probability level of
p < 0 05 was considered to be statistically significant. Data
from several neurobehavioral assays were analyzed with the
receiver operating characteristic (ROC) functions and the
relative area under the curve (AUC), and correspondent
p values are reported in Supplementary Table 1. This
analysis enables the assessment of the ability of a test to
discriminate between control and diseased animals. The
area under the curve (AUC) reflects the specificity and
sensitivity of a test and ranges from totally noninformative
(AUC = 0 5) to perfect test (AUC = 1) [41, 42].
3. Results
3.1. Cdkl5 Expression Levels in the Brain of Cdkl5 +/− and
Cdkl5 −/− Female Mice. To determine the degree of Cdkl5
levels in the brain of female Cdkl5 KO mice, we performed
Western blot assays on total protein extracts from various
brain regions from adult (3–4 months of age) wild-type
(Cdkl5 +/+), heterozygous (Cdkl5 +/−), and homozygous
(Cdkl5 −/−) Cdkl5 KO female mice. The Cdkl5 signal was
normalized to GAPDH (glyceraldehyde 3-phosphate dehy-
drogenase) levels, and the relative amounts are illustrated in
Figure 1(a). Western blot analyses showed that Cdkl5 expres-
sion levels were not uniform among the cortex, hippocam-
pus, and cerebellum (Figure 1(a)). In fact, Cdkl5 levels were
higher in the cortex, compared with the hippocampus and
cerebellum (Figure 1(a)), while the cerebellum was the brain
region that showed the lowest Cdkl5 expression levels
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Figure 1: Intermediate Cdkl5 expression levels in the brain of Cdkl5 +/− female mice. (a, b) Western blot analysis of Cdkl5 levels normalized
to GAPDH (glyceraldehyde 3-phosphate dehydrogenase) levels in the cortex (Cx), hippocampus (Hp), and cerebellum (Cb) of wild-type
(Cdkl5 +/+ n = 5), heterozygous (Cdkl5 +/− n = 6), and homozygous (Cdkl5 −/− n = 5) Cdkl5 KO female mice aged 3–4 months.
Immunoblots in (a) are examples from one animal of each experimental group, and the graph shows the relative amounts of Cdkl5
expression in the different brain structures of Cdkl5 +/+ mice. Regardless of the relative amounts, Cdkl5 expression levels were reduced to
about 35–46% in Cdkl5 +/− mice in comparison to wild-type mice and absent in Cdkl5 −/− mice in all analyzed brain regions (b). Data in
(b) are expressed as a percentage of the values of Cdkl5 +/+ mice. Values are represented as means ± SE. ∗p < 0 05 and ∗∗p < 0 001
(Mann–Whitney test after unpaired t-test).
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(Figure 1(a)). Regardless of the relative amounts, in all ana-
lyzed brain regions Cdkl5 expression levels were reduced to
about 35–46% in Cdkl5 +/− mice in comparison to wild-
type mice (Mann–Whitney test: Cx: U = 0, p = 0 0095; Hp:
U = 0, p = 0 0159; Cb: U = 0, p = 0 0043) and were absent in
Cdkl5 −/− mice (Figure 1(b)).
3.2. Reduced Body Weight and Olfactory Performance in
Cdkl5 +/− and Cdkl5 −/− Female Mice. We first evaluated
whether mutant Cdkl5 female mice showed a significant
difference in body weight. As previously reported [23], no
significant weight differences were observed in young adult
female Cdkl5 KO mice [F 2,25 = 0 9982, p = 0 3828] (8weeks
old; Figure 2(a)). However, at 14 weeks of age, the average
weight of Cdkl5 +/− and Cdkl5 −/− female mice was lower
compared with wild-type (Cdkl5 +/+) females [F 2,25 =
31 66, p < 0 0001; Fisher’s LSD: p = 0 0065 and p < 0 0001,
resp.]. Cdkl5 +/− females achieved an intermediate body
weight between that of Cdkl5 +/+ and Cdkl5 −/− female mice.
Among the many sensory stimuli that influence behav-
ioral decisions regarding food choice, olfactory inputs are
likely to contribute to food uptake and the regulation of
energy homeostasis [43]. Using the buried food test, we eval-
uated the ability of Cdkl5 +/− and Cdkl5 −/− female mice to
smell volatile odors. We found that 3month old Cdkl5 +/−
and Cdkl5 −/− female mice showed a reduced olfactory per-
formance compared with wild-type (Cdkl5 +/+) females
[Kruskal-Wallis, p = 0 0019; Dunn’s test: p = 0 0387 and
p = 0 0016, resp.] (Figure 2(b)), suggesting an olfactory
impairment in the Cdkl5 KO mice.
All the behavioral experiments described below were
performed on female Cdkl5 KO mice at 3–4 months of age.
3.3. Autistic-Like Features in Cdkl5 +/− and Cdkl5 −/−
Female Mice. To investigate whether loss of Cdkl5 function
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Figure 2: Reduced body weight, impaired olfaction, and autistic-like features in Cdkl5 +/− female mice. (a) Body weight at 8 and 14
weeks of age in Cdkl5 +/+ (n = 9), Cdkl5 +/− (n = 8 and n = 11, resp.), and Cdkl5 −/− (n = 11 and n = 8, resp.) mice. Only at 14
weeks of age Cdkl5 +/− and Cdkl5 −/−mice showed reduced body weight compared to Cdkl5 +/+ mice. (b) Olfactory ability evaluated using
the buried food test. Cdkl5 +/− (n = 15) and Cdkl5 −/− (n = 18) mice showed an increased latency to find the buried cookie compared to
Cdkl5 +/+ mice (n = 14), indicating olfactory impairment in Cdkl5 +/− and Cdkl5 −/−mice. (c) Nest building ability evaluated at 3 and 22 h.
Cdkl5 +/− (n = 9) and Cdkl5 −/− (n = 10) mice showed impaired nesting behavior compared to Cdkl5 +/+ (n = 8) mice. (d) Marble burying
test. Cdkl5 +/− (n = 19) and Cdkl5 −/− (n = 15) mice buried fewer marbles compared to Cdkl5 +/+ mice (n = 15). Values represent
mean ± SEM. ∗p < 0 05, ∗∗p < 0 01, and ∗∗∗p < 0 001 (datasets in (a), Fisher’s LSD test after ANOVA; datasets in (b–d), Dunn’s test
after Kruskal-Wallis).
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in Cdkl5 +/− and Cdkl5 −/− female mice is associated with
autistic-like (ASD-like) phenotypes, we first analyzed
home-cage social behaviors (nest building ability and marble
burying). Cdkl5 +/− and Cdkl5 −/− displayed impaired nest-
ing compared to control mice. After 3 h, Cdkl5 +/+ female
mice showed initial structured nests with a median score
of 1, while Cdkl5 +/− and Cdkl5 −/− mice showed a signifi-
cantly lower median nest quality with most of the mice
leaving the material untouched [Kruskal-Wallis, p = 0 0133;
Dunn’s test: p = 0 0461 and p = 0 0202, resp.] (Figure 2(c)).
Even after 22 h, the majority of Cdkl5 +/− and Cdkl5 −/−
mice failed to build complex structured nests with a median
nest quality of 1.4 and 0.8, respectively, in contrast to
Cdkl5 +/+ mice who had a median nest quality of 3.5
[Kruskal-Wallis, p < 0 0001; Dunn’s test: p = 0 0131 and
p < 0 0001, resp.] (Figure 2(c)).
The marble burying test was used to evaluate exploration
and environmental interest. Since marble burying may
depend not only on interest in the environment but also on
stress novelty, animals were tested after 5min of habituation.
Cdkl5 +/− and Cdkl5 −/− mice buried a significantly lower
number of marbles compared to Cdkl5 +/+ mice [Kruskal-
Wallis, p < 0 0001; Dunn’s test: p = 0 0110 and p < 0 0001,
resp.] (Figure 2(d)), suggesting that Cdkl5 +/− and Cdkl5 −/−
female mice had a decreased interest in the environment.
3.4. Impaired Motor Function in Cdkl5 +/− and Cdkl5 −/−
Female Mice. To assess whether motor impairment is present
in female Cdkl5 KO mice, we assessed motor function of
Cdkl5 +/− and Cdkl5 −/− female mice on an accelerating
rotarod assay and in the open-field test. Mice were tested
on a rotating rod for 4 trials with an intertrial interval of
1 h, and the latency to fall from the rotating rod was evalu-
ated. Cdkl5 −/− exhibited significantly reduced falling latency
compared to Cdkl5 +/+ mice in the third and fourth trials
[F 2,58 = 3 591, p = 0 0339; Fisher’s LSD: p = 0 0013 and
p = 0 0274, resp.] (Figure 3(a)). Similarly, in Cdkl5 +/−
mice the latency to fall was reduced in the last two trials
(Figure 3(a)), although the difference was statistically
significant only in the fourth trial [Fisher’s LSD: trial 3: p =
0 053, trial 4: p = 0 0185], suggesting that loss of CDKL5
impairs not only motor coordination but also motor
learning skills. We further evaluated the frequency of passive
rotations (number of passive rotations/sec), rotations in
which the mouse does not perform any coordinated
movement and is passively transported from the rotating
apparatus. Rotarod performance notably differed among
groups, with Cdkl5 +/− and Cdkl5 −/− mice showing
significantly more passive rotations during the four trials
[F 2,58 = 11 94, p < 0 0001; Fisher’s LSD: trial 1: p = 0 0006
and p = 0 0013; trial 2: p = 0 0291 and p = 0 0234; trial 3: p =
0 0225 and p = 0 0102; trial 4: p = 0 0262 and p = 0 0139,
resp.] (Figure 3(b)), confirming that both Cdkl5 +/− and
Cdkl5 −/− female mice exhibit impaired motor coordination.
To further evaluate locomotor activity, we performed an
open-field test. Cdkl5 +/− and Cdkl5 −/−mice traveled a sig-
nificantly longer distance [F 2,54 = 11 90, p < 0 0001; Fisher’s
LSD: p = 0 0116 and p < 0 0001, resp.] (Figure 3(c)) and
moved at a higher average speed [F 2,54 = 11 89, p < 0 0001;
Fisher’s LSD: p = 0 0116 and p < 0 0001, resp.] (Figure 3(d))
compared to their controls (Cdkl5 +/+), indicating elevated
locomotor activity in Cdkl5 mutants. To determine whether
this hyperactivity was caused by increased anxiety, we
compared the time spent in the border area, near the
walls, and in the center of the arena (Figure 3(f)).
Cdkl5 +/+,Cdkl5 +/−, andCdkl5 −/− spent a comparable time
at the border [F 2,54 = 1 135, p = 0 3289], near the walls
[F 2,54 = 0 6457, p = 0 5285], and in the center [F 2,54 =
0 4563, p = 0 6361] (Figure 3(f)), suggesting that the
increased locomotor activity is not due to increased anxiety.
In addition to motor dysfunction, stereotypic movements
frequently cooccur in CDKL5 patients [3]. Therefore, we
evaluated stereotypic behavior in Cdkl5 +/− and Cdkl5 −/−
mice by counting the number of repetitive jumps in the cor-
ners of the open-field arena. Cdkl5 +/− and Cdkl5 −/−
showed an increased number of stereotypical jumps com-
pared to wild-type females [Kruskal-Wallis, p < 0 0001;
Dunn’s test: p = 0 0362 and p < 0 0001, resp.] (Figure 3(e)).
An increased number in vertical jumps were also observed
in Cdkl5 KO female mice in the home-cage environment
(Cdkl5 +/+ 0± 0, Cdkl5 +/− 2.2± 1.9, and Cdkl5 −/−
1.8± 1.8), suggesting that the stereotypic behavior was not
caused by the stressful situation (the new environment).
3.5. Impaired Learning and Memory Performance in
Cdkl5 +/− and Cdkl5 −/− Female Mice. To examine whether
Cdkl5 +/− and Cdkl5 −/− female mice show cognitive impair-
ment, hippocampus-dependent learning and memory were
evaluated using the Morris water maze (MWM). Mice were
tested for their ability to find a hidden platform for 5 days
(learning phase) and were subjected to the probe test
on day 6. A repeated ANOVA on escape latency during
the learning phase revealed a significant genotype effect
[F 2,52 = 28 03, p < 0 0001]. In the learning phase, both
Cdkl5 +/− and Cdkl5 −/− mice showed a reduced ability
to learn over time compared to Cdkl5 +/+ mice [Fisher’s
LSD: day 2: p = 0 0010 and p < 0 0001; day 3: p = 0 0033
and p < 0 0001; day 4: p = 0 0008 and p < 0 0001; day 5:
p < 0 0001 and p < 0 0001, resp.] (Figure 4(a)). While
Cdkl5 +/+ mice exhibited a fast learning improvement
with time and learned to find the platform by the second
day [Fisher’s LSD: p < 0 0001], significant learning was
detected in Cdkl5 +/− and Cdkl5 −/− mice by the third
day [Fisher’s LSD: p < 0 0001 and p = 0 015, resp.], indi-
cating a learning deficit in both genotypes. No significant
differences in the learning curves were observed between
the Cdkl5 +/− and Cdkl5 −/− mice in the first two days
of training (Figure 4(a)), while Cdkl5 −/− mice showed
a greater impairment in finding the hidden platform in
the following days [Fisher’s LSD: day 3: p = 0 0015; day 4:
p = 0 0020; and day 5: p = 0 0049].
Performance in the MWM is influenced by sensorimotor
function and motivation, and these parameters can be
assessed using swimming patterns such as swim speed and
floating (rest time). No difference in maximum swim speed
was observed among Cdkl5 +/+, Cdkl5 +/−, and Cdkl5 −/−
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mice [F 2,52 = 0 4431, p = 0 6445] (Figure 4(b)), indicating
that the deficit of Cdkl5 +/− and −/−mice in the hidden plat-
form test was not caused by abnormalities in locomotor activ-
ity or coordination. On the contrary, average swim speed
significantly decreased in Cdkl5 +/−mice and Cdkl5 −/−mice
[F 2,52 = 28 21, p < 0 0001; Fisher’s LSD: p = 0 0003 and
p < 0 0001, resp.] (Figure 4(c)). Even relatively short inter-
vals of floating behavior can cause significant changes in
the mean raw average speed of a trial. We quantified the
number of trials with floating episodes during training across
genotypes (Figure 4(d)). An analysis of floating episodes
revealed that Cdkl5 −/− mice showed a significantly higher
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Figure 3: Impaired motor coordination, hyperactivity, and stereotypes in Cdkl5 +/− female mice. (a, b) Rotarod assay, measuring latency to
fall (a) and frequency of passive rotations (b; rotations in which the mouse does not perform any coordinated movement but is passively
transported from the rotating apparatus) on the accelerating rotating rod. Testing was performed in 4 trials with an intertrial interval of
1 h. Cdkl5 +/− (n = 21) and Cdkl5 −/− (n = 23) mice showed a decreased latency to fall (a) and an increased frequency of passive rotations
compared to Cdkl5 +/+ (n = 17) mice, indicating impaired motor coordination in Cdkl5 +/− and Cdkl5 −/− mice. (c, d) Locomotor
activity measured as total distance traveled (c) and average locomotion velocity (d) during a 20min open-field test. Cdkl5 +/− (n = 19) and
Cdkl5 −/− (n = 22) mice exhibited increased locomotor activity with a longer total distance traveled (c) at a greater average speed (d)
compared to Cdkl5 +/+ (n = 16) mice. (e) Number of stereotypic jumps (repetitive beam breaks < 1 s) in the corners of the open-field
arena during the 20min trial. Cdkl5 +/− (n = 19) and Cdkl5 −/− (n = 21) mice showed an increased number of repetitive stereotyped
jumps compared to Cdkl5 +/+ (n = 15) mice. (f) Time (cumulative duration) spent by the border, near the walls, and in the center of the
open-field arena. Cdkl5 +/+, Cdkl5 +/−, and Cdkl5 −/− mice spent a comparable time at the border, near the walls, and in the center
compared to controls, suggesting that hyperactivity was not due to increased anxiety. Values represent mean ± SEM. ∗p < 0 05, ∗∗p < 0 01,
and ∗∗∗p < 0 001 (datasets in (a–d, f), Fisher’s LSD test after ANOVA; datasets in (e) Dunn’s test after Kruskall-Wallis).
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Figure 4: Impaired hippocampus-dependent learning and memory in Cdkl5 +/− female mice. (a) Spatial learning assessed using the Morris
water maze. Cdkl5 +/− (n = 20) and Cdkl5 −/− (n = 19) mice showed an increased latency to find the platform over the 5-day learning period
compared to the Cdkl5 +/+ (n = 16) mice. (b, c) Maximum (b) and average (c) swim speed during the learning phase in mice as in (a). (d)
Percentage of floating, defined as the percentage of time swimming at less than 4 cm/s during the learning phase in mice as in (a). (e–h) On
day 6 (probe test), the platform was removed and spatial memory was assessed by evaluating different parameters. Cdkl5 +/− and Cdkl5 −/−
mice showed an increased latency to enter the former platform zone (e), a reduced frequency to enter (f), and time spent in the quadrant (g)
in which the platform had been located during the learning period. In addition, Cdkl5 +/− and Cdkl5 −/− mice swam a larger distance from
the former platform (h) compared to the Cdkl5 +/+ mice, indicating defects in spatial memory. Values represent mean ± SEM. ∗p < 0 05,
∗∗p < 0 01, and ∗∗∗p < 0 001 as compared to the Cdkl5 +/+ female mice; #p < 0 05 as compared to the Cdkl5 +/− female mice (dataset in
a); ∗p < 0 05, ∗∗p < 0 01, and ∗∗∗p < 0 001 as compared to the Cdkl5 +/+ or Cdkl5 +/− female mice (dataset in b–h), Fisher’s LSD test
after ANOVA; datasets in (d), Dunn’s test after Kruskall-Wallis).
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percentage of floating behaviors compared to Cdkl5 +/+ mice
[Kruskal-Wallis, p < 0 0001; Dunn’s test: p < 0 0001]
(Figure 4(d)), while Cdkl5 +/− mice showed a slightly, but
not significantly, increased number of floating episodes
[Dunn’s test: p = 0 1716] (Figure 4(d)). These results suggest
that an increased level of floating behavior can account for
the reduced swimming speed of Cdkl5 +/− and Cdkl5 −/−
mice. Thigmotaxis (swimming along the walls of the pool)
was not observed among Cdkl5 female genotypes.
In the probe test, the following parameters were consid-
ered as an index of spatial memory: (i) latency to enter the for-
mer platform zone (Figure 4(e)), (ii) frequency of entrances
into the former platform quadrant (Figure 4(f)), (iii) time
spent in the former platform quadrant (Figure 4(g)), and
(iv) proximity to the former platform position (Gallagher’s
test) (Figure 4(h)). Performance in all examined parameters
was significantly impaired in Cdkl5 +/− and Cdkl5 −/− mice.
Both showed an increase in the latency to enter the former
platform zone [F 2,52 = 21 70, p < 0 0001; Fisher’s LSD:
p = 0 0026 and p < 0 0001, resp.] (Figure 4(e)), a reduction
in the frequency of entrances [F 2,52 = 22 72, p < 0 0001;
Fisher’s LSD: p = 0 0003 and p < 0 0001, resp.] (Figure 4(f)),
a reduction in the time spent there [F 2,52 = 11 33,
p < 0 0001; Fisher’s LSD: p = 0 0195 and p < 0 0001, resp.]
(Figure 4(g)), and a reduction in the proximity to the platform
quadrant [F 2,52 = 10 25, p = 0 0002; Fisher’s LSD: p = 0 0176
and p < 0 0001, resp.] (Figure 4(h)).
To confirm the observed defects in memory, we per-
formed a second test, the passive avoidance test. In this task,
animals are conditioned with a single aversive event (mild
foot shock) and 24h later are tested for recollection of that
experience. Figures 5(a) and 5(b) show the latency to enter
the dark compartment on the first and second days of the
test. While no difference in step-through latency was
observed on the first day [Kruskal-Wallis, p = 0 8028]
(Figure 5(a)), Cdkl5 +/− and Cdkl5 −/− mice show a signifi-
cantly decreased latency on the second day [Kruskal Wallis,
p = 0 0049; Dunn’s test: p = 0 0209 and p = 0 0073, resp.]
(Figure 5(b)), suggesting a defect in associative memory.
3.6. Abnormal Breathing Pattern in Cdkl5 +/− and Cdkl5 −/−
Female Mice. To determine whether breathing irregulari-
ties and sleep disturbance are present in Cdkl5 +/− and
Cdkl5 −/− females, hypnic and respiratory phenotypes
were assessed using noninvasive whole-body plethysmogra-
phy (WBP). Cdkl5 +/− and Cdkl5 −/− females had more
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Figure 5: Impaired memory in Cdkl5 +/− female mice. (a, b) Passive avoidance task to measure memory that involves contributions from
both the hippocampus and amygdala. On the first day (a), no difference was observed between genotypes regarding the latency to enter
the dark compartment. On the second day, Cdkl5 +/− (n = 12) and Cdkl5 −/− (n = 14) mice showed a decreased latency to enter the dark
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∗∗p < 0 01 (Dunn’s test after Kruskall-Wallis).
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Figure 6: Sleep apnea occurrence rate in Cdkl5 +/− female mice. (a, c) Apnea occurrence rate during NREM sleep (a), REM sleep (b), and
total sleep period (c). Cdkl5 +/− (n = 11) and Cdkl5 −/− (n = 8) mice showed an increased number of apneas during NREM sleep (a) and,
consequently, an increased number of total sleep apneas (c) compared to Cdkl5 +/+ (n = 9) mice. Values represent mean ± SEM. ∗p < 0 05,
∗∗p < 0 01, and ∗∗∗p < 0 001 (Fisher’s LSD test after ANOVA).
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frequent apneas during NREM sleep [F 2,25 = 13 26, p =
0 0001; Fisher’s LSD: p = 0 0249 and p < 0 0001, resp.] and
during total sleep time [F 2,25 = 13 57, p = 0 0001; Fisher’s
LSD: p = 0 0238 and p < 0 0001, resp.] compared to Cdkl5
+/+ female mice (Figures 6(a) and 6(c)), but not during
REM sleep [F 2,25 = 1 384, p = 0 2691] (Figure 6(b)), con-
firming the presence of an impaired breathing pattern in
heterozygous and homozygous Cdkl5 female mice.
3.7. Cdkl5 +/− and Cdkl5 −/− Female Mice Exhibit Altered
Neuronal Maturation and Synapse Development. Changes
in neuronal morphology, including defects in neuronal
maturation, alterations in the organization and stability of
dendritic spines, and defects in synaptogenesis, have been
consistently reported in male Cdkl5 KO mice [20, 22–25,
33–35]. To determine whether similar defects were also pres-
ent in heterozygous and homozygous Cdkl5 female mice, we
analyzed dendritic development and spine density/morphol-
ogy in Golgi-stained granule neurons of the dentate gyrus
(DG) from 3–4 month-old females. Total dendritic
length [F 2,8 = 40 28, p < 0 0001; Fisher’s LSD: p = 0 0023
and p < 0 0001, resp.] and number of dendritic branches
[F 2,8 = 37 34, p < 0 0001; Fisher’s LSD: p = 0 0041 and
p < 0 0001, resp.] of granule neurons were reduced in
Cdkl5 +/− and Cdkl5 −/− females compared to their wild-
type counterparts (Figures 7(a)–7(c)). Evaluation of dendritic
spine density showed that granule neurons of Cdkl5 +/− and
Cdkl5 −/− females had reduced spine density [F 2,8 = 9 355,
p = 0 008; Fisher’s LSD: p = 0 0445 and p = 0 0026, resp.]
in comparison with wild-type (+/+) mice (Figures 7(d)
and 7(f)). Moreover, separate counts of different classes
of dendritic spines revealed that granule neurons of both
genotypes had a higher percentage of immature spines
(filopodium-like, thin-shaped, and stubby-shaped) and a
reduced percentage of mature spines (chi-squared test:
p = 0 0153 and p = 0 0196, resp.) compared to +/+ mice
(Figures 7(e) and 7(f)). Since dendritic spine structure
is fundamental for synaptic contact maintenance, we further
evaluated the number of immunoreactive puncta for PSD-95
(postsynaptic density protein 95) in the molecular layer of
the hippocampal dentate gyrus of heterozygous and homozy-
gous Cdkl5 female mice. Cdkl5 −/− females displayed a
strong reduction in the number of PSD-95-positive puncta
[F 2,8 = 30 66, p = 0 0002; Fisher’s LSD: p < 0 0001] com-
pared to Cdkl5 +/+ female mice (Figures 7(g) and 7(h)), while
Cdkl5 +/−mice showed intermediate levels of PSD-95 puncta
(p = 0 0007) (Figures 7(g) and 7(h)).
3.8. Cdkl5 +/− and Cdkl5 −/− Female Mice Exhibit Age-
Related Alterations in AKT and ERK Signaling Pathways.
We examined whether the AKT signaling pathway, known
to be altered in Cdkl5 KO male mice [22, 23, 25], is similarly
affected in adult Cdkl5 +/− and Cdkl5 −/− female mice. Sur-
prisingly, Western blots on hippocampal and cerebellar
extracts from adult (3–4 months of age) Cdkl5 KO females
revealed no change in P-AKT-Ser473 levels [F 2,13 = 1 846,
p = 0 1970 and F 2,12 = 1 460, p = 0 2720, resp.] (Figures 8(a)
and 8(b)). Likewise, no change in β-catenin levels, an AKT
downstream target, was observed in hippocampal extracts
[F 2,10 = 0 1222, p = 0 8863] (Supplementary Figure 1A).
Interestingly, decreased levels of phosphorylated ERK1/2
were observed in extracts of the hippocampus [F 2,13 =
7 897, p = 0 0057; Fisher’s LSD: p = 0 0071 and p = 0 0027,
resp.] and cerebellum [F 2,17 = 4 465, p = 0 0276; Fisher’s
LSD: p = 0 0170 and p = 0 0191, resp.] from both Cdkl5 +/−
and Cdkl5 −/− female mice, when compared to their wild-
type counterparts (Figures 8(a) and 8(b)). In line with
decreased P-ERK1/2 levels, we found decreased levels of
phosphorylated MSK1 (P-MSK1-Thr581; mitogen- and
stress-activated protein kinase), a ERK1/2 downstream phos-
phorylation target, in the hippocampus of adultCdkl5+/− and
Cdkl5 −/− mice [F 2,13 = 4 685, p = 0 0294; Fisher’s LSD:
p = 0 0385 and p = 0 0119, resp.] (Supplementary Figure 1A).
In order to evaluate whether there are age-related
changes in AKT and ERK1/2 signal pathways in Cdkl5 KO
mice, we analyzed P-AKT-Ser473, β-catenin, P-ERK1/2,
and P-MSK1-Thr581 levels in the hippocampus of juvenile
(3week old) and young adult (8 week old) Cdkl5 KO female
mice. In line with previous results [23, 25, 35], we found that
juvenile Cdkl5 +/− and Cdkl5 −/− mice show reduced P-
AKT-Ser473 [F 2,6 = 7 844, p = 0 0212; Fisher’s LSD: p =
0 0253 and p = 0 0094, resp.] and β-catenin levels [F 2,10 =
6 635, p = 0 0147; Fisher’s LSD: p = 0 0065 and p = 0 0169,
resp.] (Supplementary Figure 1B) in comparison with their
wild-type counterparts. Differently, no changes in P-
ERK1/2 [F 2,10 = 1 241, p = 0 3299] and P-MSK1-Thr581
[F 2,12 = 0 0720, p = 0 9309] levels were observed in juvenile
Cdkl5 KO female mice (Supplementary Figure 1C). Western
blots on hippocampal extracts from young adult Cdkl5 +/−
and Cdkl5 −/− KO females revealed that both genotypes
show decreased P-AKT-Ser473 [F 2,11 = 5 076, p = 0 0274;
Fisher’s LSD: p = 0 0566 and p = 0 0093, resp.] and P-
ERK1/2 [F 2,9 = 5 711, p = 0 0250; Fisher’s LSD: p =
0 0174 and p = 0 0124, resp.] levels (Supplementary Figure
1E), compared to their wild-type counterparts. In accor-
dance, β-catenin [F 2,13 = 6 907, p = 0 0090; Fisher’s LSD:
p = 0 0560 and p = 0 0026, resp.] (Supplementary Figure
1D) and P-MSK1-Thr581 [F 2,9 = 8 202, p = 0 0094; Fish-
er’s LSD: p = 0 0110 and p = 0 0036, resp.] (Supplementary
Figure 1E) levels were reduced in Cdkl5 +/− and Cdkl5 −/−
female mice.
4. Discussion
Animal models of neurological disorders serve as one of the
most valuable tools for the development and validation of
potential therapies. They enable scientists to test the safety
and efficacy of new therapeutic agents in vivo and to acquire
a detailed understanding of mechanisms of action for new
drugs, in order to speed therapies along toward human clin-
ical trials. Since the majority of CDKL5 patients are females
with heterozygous CDKL5 mutations, the behavioral and
molecular characterization of heterozygous Cdkl5 KO
(Cdkl5 +/−) female mice is of utmost importance in order
to advance preclinical and translational studies. In the
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present study, we found that heterozygous Cdkl5 female
mice recapitulate several behavioral aspects of CDKL5 disor-
der including autistic-like behaviors, motor impaired behav-
ior, learning and memory disability, and abnormal breathing
pattern. These phenotypes have been described in CDKL5
patients [3, 4, 7] and may mimic the absence of hand
skills, the intellectual disability, hyperactivity, poor response
to social interactions, and breathing problems that have been
described. Heterozygous Cdkl5 KO female mice, similarly to
Cdkl5 male mice [20, 24, 33–35], show neuroanatomical
defects, including dendritic hypotrophy and defects in spine
density/maturation. Moreover, we found that loss of Cdkl5
in Cdkl5KO female mice impaired, in an age-related manner,
phosphorylation levels of the protein kinase B (Akt) and the
⁎⁎
⁎⁎⁎
⁎⁎
1500
1000
To
ta
l d
en
dr
iti
c
le
ng
th
 (𝜇
m
)
500
0
+/+ +/− −/−
(a)
⁎⁎
⁎⁎⁎
⁎⁎
50
40
30
20
10
0
N
um
be
r o
f b
ra
nc
he
s
+/+ +/− −/−
(b)
+/+ +/− −/−
(c)
⁎
⁎⁎
Sp
in
es
 (𝜇
m
)
2.0
1.5
1.0
0.5
0.0
+/+ +/− −/−
(d)
+/+ +/− −/−
⁎
⁎
120
100
80
60
40
20
0
Pe
rc
en
ta
ge
 o
f s
pi
ne
s
Immature
Mature
(e)
+/+ +/− −/−
(f)
⁎⁎⁎
⁎⁎⁎
⁎
PS
D
95
 p
un
ct
a (
𝜇
m
)
1.5
1.0
0.5
0.0
+/+ +/− −/−
(g)
+/+ +/− −/−
(h)
Figure 7: Impaired hippocampal development in Cdkl5 +/− female mice. (a, b) Mean total dendritic length (a) and mean number of dendritic
branches (b) of Golgi-stained mature granule neurons of Cdkl5 +/+ (n = 4), Cdkl5 +/− (n = 3), and Cdkl5 −/− (n = 4) mice. (c) Examples of the
reconstructed dendritic tree of Golgi-stained mature granule neurons of one animal from each experimental group. (d, e) Dendritic spine
density (number of spines per μm; d) and percentage of immature and mature spines (e) in relation to the total number of protrusions of
granule neurons of mice as in (a). (f) Examples of Golgi-stained dendritic branches of mature granule neurons of one animal from each
experimental group. The black triangles indicate mature spines (mushroom- and cup-shaped spines). Scale bar: 1μm. (g) Number of
fluorescent puncta per μm2 exhibiting PSD-95 immunoreactivity in the molecular layer of the dentate gyrus of Cdkl5 +/+ (n = 4),
Cdkl5 +/− (n = 4), and Cdkl5 −/− (n = 3) mice. (h) Confocal images of sections processed for PSD-95 immunohistochemistry of one
animal from each experimental group. Scale bar: 2.5 μm. Values represent mean ± SEM. ∗p < 0 05, ∗∗p < 0 01, and ∗∗∗p < 0 001
(datasets in (a–c, e–h), Fisher’s LSD test after ANOVA; datasets in (d), Dunn’s test after Kruskall-Wallis).
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extracellular signal-regulated kinase (ERK1/2), important
signaling mediators in brain function. Therefore, we believe
that heterozygous Cdkl5 KO female mice are a valuable tool
for further studies aimed at improving the neurological phe-
notype due to mutations in CDKL5.
4.1. General Health and Sensory Abnormalities. Although no
significant difference was observed in body weight among
young adult wild-type, heterozygous, and homozygous Cdkl5
female mice ([23] and present study), we found that adult
heterozygous and homozygous Cdkl5 females showed a
lower body weight than did age-matched wild-type females.
The decreased weight gain observed in heterozygous and
homozygous Cdkl5 female mice might be secondary to
increased energy expenditure, resulting from both an
increased basal metabolic rate and locomotor activity. Since
olfactory inputs help coordinate food appreciation and
selection, but have an important role in energy balance,
influencing body weight [43], our finding that heterozygous
and homozygous Cdkl5 female mice showed reduced
olfaction could be an explanation for the decreased weight
gain. On the other hand, increased locomotor activity and
locomotion stereotypes, such as elevated vertical activity
(vertical jumps), observed in heterozygous and homozygous
Cdkl5 female mice, could influence body weight by increasing
energy expenditure. With regard to reduced olfaction, it
remains to be established whether alterations in the neuronal
circuitry of the olfactory bulb and/or a reduced neurogenesis
underlie this defect in Cdkl5 KO mice.
4.2. Autism-Like Features. Autistic-like (ASD-like) features,
including deficits in social interaction, disinterest for the sur-
rounding environment, and stereotypic/repetitive behaviors,
have been commonly described in CDKL5 patients [44, 45]
and male Cdkl5 KO mouse models [22, 32]. Our finding that
heterozygous and homozygous Cdkl5 female mice show
impaired social behaviors (reduced nest building ability),
decreased interest toward the environment (reduced marble
burying), and increased stereotypic behaviors (elevated
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Figure 8: Altered ERK signaling pathway in Cdkl5 +/− female mice. (a) Western blot analysis of P-AKT-Ser 473 levels normalized to total
AKT levels (left histograms) and P-ERK-Ser 42–44 levels normalized to total ERK levels (right histograms) in the hippocampus (a) and
cerebellum (b) of Cdkl5 +/+ (n = 6 and n = 5, resp.), Cdkl5 +/− (n = 6 and n = 8, resp.), and Cdkl5 −/− (n = 6 and n = 5, resp.) mice.
Immunoblots are examples from one animal of each experimental group. Data are expressed as a percentage of the values of Cdkl5 +/+
mice. Values are represented as means ± SE. ∗p < 0 05 and ∗∗p < 0 01 (Fisher’s LSD after ANOVA).
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vertical activity in novel environments) suggests that the het-
erozygous Cdkl5 female mouse model mirrors the ASD-like
features of CDKL5 female patients.
4.3. Motor Abnormalities. Motor dysfunction is a prominent
feature of CDKL5 deficiency, with the majority of patients
having some degree of impairment in gross and fine motor
skills, including gait dysfunction and defects in sitting, stand-
ing, walking, and grasping [45]. Consistent with this severe
motor phenotype in female CDKL5 patients and with previ-
ous data in male Cdkl5 KO mice [22, 23, 31, 32], we found
impaired motor coordination, assessed using the accelerating
rotarod assay, and novel environment-dependent hyperac-
tivity in heterozygous and homozygous Cdkl5 KO female
mice. Since female Cdkl5 KO mice had a tendency to ride
the rotarod beam around rather than walk forward, in addi-
tion to the latency to fall from the rotating rod, we scored
the frequency of these passive rotations. While hanging onto
the rotating rod is not commonly seen in wild-type mice, we
found that both homozygous and heterozygous Cdkl5 KO
female mice showed an increased frequency of uncoordi-
nated rotations, indicating a serious difficulty in motor coor-
dination. Cdkl5 KO female mice showed higher levels of
activity in the open field similar to what has been described
in male Cdkl5 KO mice [22, 32, 35]. This hyperactivity
was not related to changes in emotionality/anxiety, as it
did not affect the activity in the central part of the field
(increased exploration at the edges/walls compared to the
center of the arena).
4.4. Cognitive Impairments. Severe intellectual disability is a
central feature of human CDKL5 deficiency [44]. Impair-
ment in learning and memory is also a consistent feature in
male Cdkl5 KO mice [20, 22, 24, 25, 30, 32, 35]. A marked
phenotype of heterozygous and homozygous Cdkl5 females
was attained in the spatial learning and memory paradigm.
The acquisition of allocentric learning was markedly
impaired in Cdkl5 KO female mice, thus reinforcing the con-
cept that loss of Cdkl5 is affecting hippocampal learning and
memory function. Since learning/memory defects evaluated
in the Morris water maze task might be influenced by the dif-
ferences in swimming speed or in the motivational/motor
(floating behavior) aspects observed between wild-type and
Cdkl5 KO female mice, we also tested memory in a passive
avoidance test [24]. Again, heterozygous and homozygous
Cdkl5 KO female mice showed a substantial memory impair-
ment (−40%), reinforcing the concept that loss of Cdkl5 leads
to alterations in the acquisition process.
4.5. Respiratory Problems. To complete our neurobehavioral
studies, we monitored breathing pattern, a physiological
parameter. Respiratory problems, including the presence
and frequency of breathing irregularities (hyperventilation,
apnea), are a reported feature in CDKL5 patients [46, 47].
Moreover, disrupted respiratory function and an increased
number of apneas during sleep have been recently described
also in male Cdkl5 KO mice [40, 48]. We observed a similar
increase in apnea occurrence during NREM sleep and during
the whole sleep time in heterozygous and homozygous Cdkl5
KO female mice, strengthening the statement that the sleep
apnea occurrence rate can be a significant biomarker for
validation of future therapies in CDKL5 disorder.
4.6. Hippocampal Neuroanatomical Defects. Several studies
have shown that Cdkl5 KO male mice, in addition to var-
ious behavioral abnormalities, exhibit profound changes
in neuronal morphology [20, 22–25, 33–35]. Moreover,
these neuroanatomical alterations, including defects in
neuronal survival and maturation and defects in the orga-
nization of dendritic spines as well as in the density of
PSD-95 dendritic clusters, have been shown to be instrumen-
tal as preclinical readouts for testing potential therapeutics
[20, 24, 33, 35]. Our present findings that heterozygous Cdkl5
KO females show altered neuronal maturation and synapse
development confirm that cellular phenotypes, in addition
to behavioral phenotypes, are useful outcome measures in
preclinical studies.
4.7. Pathway Dysfunctions. In line with previous evidence
[23, 25], we found that juvenile Cdkl5 KO female mice show
an alteration in the AKT pathway but no differences in the
phosphorylation levels of ERK1/2 in the hippocampal region.
Our present findings that young adult (8 week old) Cdkl5 KO
female mice show defects in both AKT and ERK signaling
pathways, while adult (3–4 months of age) Cdkl5 KO females
show a strong reduction in ERK1/2 phosphorylation, but no
alterations in AKT phosphorylation levels might be
explained by age-related changes in the activation and/or
modulation of these pathways [49, 50]. Interestingly, AKT
is highly expressed in the developing mouse brain but is pres-
ent at low levels in the adult brain [51]. On the other hand,
ERK1/2 is abundant in the adult brain, and its activation
can play multiple roles in the activity-dependent regulation
of neuronal function [52]. Consistent with its critical role in
key cellular activities, dysregulation of ERK signaling has
been implicated in the pathogenesis of many neuropsychiat-
ric and neurological disorders including autism [53], mental
retardation [54], and several neurodegenerative diseases such
as Alzheimer’s disease, Parkinson’s disease, and amyotrophic
lateral sclerosis [55]. Our data, showing age-related changes
in AKT and ERK signaling pathways in Cdkl5 KOmice, indi-
cate that the changes in signaling pathways occurring during
the stage of early brain development due to loss of Cdkl5 dif-
fer from those that present later on in adulthood. The direct
functional effects of these changes on CDKL5 pathogenesis
are not yet known. However, the age dependence of these
alterations suggests that the efficacy of signaling pathway-
targeted therapeutics may be limited to different develop-
mental periods.
4.8. Mosaic Cdkl5 Expression and Phenotypic Outcomes.
Heterozygous female CDKL5-deficient patients show a vast
clinical heterogeneity that spans from milder forms—with
less severe epilepsy and less severe comorbidities—to more
severe forms featuring intractable seizures and the lack of
achievement of developmental milestones [45]. As seen for
other dominant X-linked disorders [56], this clinical hetero-
geneity might be, at least in part, dependent on the
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phenomenon of variable XCI in heterozygous females. Blood
analysis in CDKL5 female patients indicates a random (50%)
XCI pattern [44, 57–59], suggesting that different phenotypes
are not the result of X-inactivation status. However, XCI
skewing is difficult to prove in human brains, since it is fre-
quently measured indirectly from peripheral blood samples
and it is difficult to determine whether the same XCI ratio
is also present in the brain. Furthermore, the distribution of
XCI in the brain may differ from region to region due to its
tissue-specific variation [60]. As previously reported [9, 10],
we found that Cdkl5 levels vary between the individual brain
areas, with the highest Cdkl5 levels in the cortex and hippo-
campus and lower levels in the cerebellum. In all analyzed
brain regions, we found that Cdkl5 +/− mice show average
decreased levels of Cdkl5 to ∼42% of those contained in
wild-type counterparts. Our results, which show little vari-
ability in Cdkl5 protein expression among the Cdkl5 +/−
brain samples, provide a first indication of balanced XCI pat-
terns in heterozygous Cdkl5 KO mouse brains. This might
explain the relatively small degree of phenotypic variability
among heterozygous female mice. Moreover, the putative
skewing toward the mutated X chromosome found in the
hippocampus of heterozygous females (decreased levels of
Cdkl5 ∼ 36%) could explain the severe phenotypic outcome
in hippocampus-dependent behaviors that is more similar
to homozygous Cdkl5 KO female and hemizygous Cdkl5
KO male mice (Table 1) [20, 35, 61]. Further studies based
on Cdkl5 single-cell based immunodetection in heterozygous
brains are required to accurately evaluate whether XCI
influences the phenotypic outcome of loss of Cdkl5 in hetero-
zygous female mice.
By comparing the behavioral results obtained in this
study with literature data (Table 1), we found that heterozy-
gous Cdkl5 KO females develop behavioral abnormalities
that are comparable, albeit milder, to defects identified in
homozygous Cdkl5 KO (Cdkl5 −/−) female and hemizygous
Cdkl5 KO (Cdkl5 −/Y) male mice. The assessment of specific-
ity and sensitivity of the behavioral tests to discriminate
between control and Cdkl5 KO female mice (ROC analysis;
Supplementary Table 1) shows that several behaviors,
including autistic-like (i.e., nest building) and cognitive
behaviors (i.e., passive avoidance), and brain functions,
such as sleep patterns, had AUC values > 0 8, indicating
that they might be reliable preclinical readouts for testing
the translational potential of therapeutics in females.
Despite the presence of numerous neurobehavioral
defects, both Cdkl5 KO male and female mice do not show
spontaneous epilepsy, a hallmark clinical feature of CDKL5
disorder. Even if alterations in the excitatory/inhibitory
balance, frequently postulated as a mechanism underlying
epileptogenesis and seizure, were observed in Cdkl5 KOmice
[31, 34], it is likely that the differences of neural connectivity
between humans and mice might underlie the different
seizure susceptibility in the Cdkl5 KO mouse model.
4.9. Conclusions. Recent studies in Cdkl5 KO mice have
revealed different mechanisms that might be therapeutically
manipulated and have produced compelling evidence that
signaling pathways downstream of CDKL5 can effectively
be targeted to ameliorate CDKL5-related symptoms in mice
[20, 24, 33]. However, the majority of work involving Cdkl5
mouse models has focused on the loss of Cdkl5 in male
mice, avoiding the potential cofounding effects of variable
X-chromosome inactivation (XCI) in female mice. Our study
provides a comprehensive overview of neurobehavioral and
physiological phenotypes of the heterozygous female Cdkl5
KOmouse and demonstrates that this mouse model recapitu-
lates multiple features observed in CDKL5 patients; therefore,
it might be considered a valuable animal model for future
therapeutic studies.
Data Availability
The data used to support the findings of this study are
available from the corresponding author upon request.
Additional Points
Highlights. Heterozygous Cdkl5 KO female mice show
autism-like behaviors and defects in motor coordination.
Heterozygous Cdkl5KO female mice show defects in learning
and memory performance. Heterozygous Cdkl5 KO female
mice show breathing abnormalities. Heterozygous Cdkl5
KO female mice show age-related alterations of the ERK1/2
Table 1: Comparison of behavioral phenotypes in Cdkl5 KO female and male mice.
Cdkl5 +/− Cdkl5 −/− Cdkl5 −/Y
Olfactory performance Buried food test +++ +++ na
Autistic-like features
Nest building 22 hours +++ +++ +++ [22]
Marble burying ++ +++ na
Motor function
Rotarod∗ + + ++ [22, 32]
Open field + ++ +++ [32]
Learning and memory
Morris water maze learning∗∗ ++ +++ +++ [20, 24]
Morris water maze probe +++ +++ +++ [20, 24]
Passive avoidance ++ ++ +++ [24]
Breathing Sleep apneas +++ +++ +++ [40]
Phenotypes are compared to their sex-matched wild-type condition. +, 10–25% of difference; ++, 25–50% of difference; and +++, >50% of difference. na: not
assessed. ∗Average of all trials; ∗∗average of latency day 2–day 5.
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and AKT pathways. Heterozygous Cdkl5 KO female mice
recapitulate multiple features observed in CDKL5 patients.
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Supplementary Materials
Supplementary 1. Supplementary Figure 1: age-dependent
alteration in AKT and ERK signaling pathways in Cdkl5 +/−
and Cdkl5 −/− female mice. A: Western blot analysis of
β-catenin levels normalized to GAPDH (glyceraldehyde
3-phosphate dehydrogenase) levels (left histogram) and
P-MSK1-Thr 581 levels normalized to GAPDH (right his-
togram) in the hippocampus of 12–14 week old Cdkl5 +/+
(n = 4 and n = 6, resp.), Cdkl5 +/− (n = 5) and Cdkl5 −/−
(n = 4 and n = 5, resp.) mice. B: Western blot analysis of
P-AKT-Ser 473 levels normalized to total AKT levels (left
histogram) and β-catenin levels normalized to GAPDH
levels (right histogram) in the hippocampus of 3 week
old Cdkl5 +/+ (n = 3 and n = 4, resp.), Cdkl5 +/− (n = 3
and n = 4, resp.), and Cdkl5 −/− (n = 3 and n = 5, resp.) mice.
C: Western blot analysis of P-ERK-Ser 42–44 levels normal-
ized to total ERK levels (left histograms) and P-MSK1-Thr
581 levels normalized to GAPDH (right histogram) in the
hippocampus of 3 week old Cdkl5 +/+ (n = 4 and n = 5, resp.),
Cdkl5 +/− (n = 4 and n = 5, resp.), and Cdkl5 −/− (n = 4 and
n = 5, resp.) mice. D: Western blot analysis of P-AKT-Ser
473 levels normalized to total AKT levels (left histograms)
andβ-catenin levels normalized to GAPDH (right histogram)
levels in the hippocampus of 8 week old Cdkl5 +/+ (n = 4 and
n = 5, resp.), Cdkl5 +/− (n = 4 and n = 5, resp.), and Cdkl5 −/−
(n = 6) mice. E: Western blot analysis of P-ERK-Ser 42–44
levels normalized to total ERK levels (left histograms) and
P-MSK1-Thr 581 levels normalized to GAPDH (right histo-
gram) in the hippocampus of 8 week old Cdkl5 +/+ (n = 3),
Cdkl5 +/− (n = 5), and Cdkl5 −/− (n = 4) mice. Immunoblots
are examples from one animal of each experimental group.
Data are expressed as a percentage of the values of
Cdkl5 +/+ mice. Values are represented as means ± SE.
∗p < 0 05 and ∗∗p < 0 01 (Fisher’s LSD after ANOVA).
Supplementary 2. Supplementary Table 1: ROC analysis on
neurobehavioral and functional assays. The relative area
under the curve (AUC) and correspondent p values are
reported. The area under the curve (AUC) reflects the speci-
ficity and sensitivity of a test and ranges from totally nonin-
formative (AUC = 0 5) to perfect test (AUC = 1).
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